Adverse events associated with benznidazole treatment for Chagas disease in children and adults

Documenti analoghi

• Fixed dosing of alpelisib for children with vascular anomalies: Can we do better?
  di: Amandine Remy, et al.
  Pubblicazione: (2025)
• Adverse events associated with monoclonal antibodies used for treatment of COVID‐19: A systematic review and meta‐analysis
  di: Htet Htet, et al.
  Pubblicazione: (2025)
• Correction to “Incidence and trend of cardiac events among children and young adults exposed to psychopharmacological treatment (2006–2018): A nationwide register‐based study”
  Pubblicazione: (2025)
• A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti‐Shiga toxin hyperimmune equine F (ab′)2 fragments in healthy volunteers
  di: Yanina Hiriart, et al.
  Pubblicazione: (2024)
• Resolution pharmacology and the treatment of infectious diseases
  di: Vivian Vasconcelos Costa, et al.
  Pubblicazione: (2024)